This isn't just another tech raise

Ajouté : 2026-05-19

[00:00:00]A drug lab just got $2 billion. This is an AI-driven lab, and it's going to be crazy. So, to tell you a story, my dad got diagnosed with CLL, which is a chronic form of leukemia cancer, and he was given a miracle drug. Instead of having to do chemotherapy, which kills all of your cells and makes well, not all of them, but a lot of them, it makes you very, very sick.

[00:00:32]He was given one of the few cancer treatments where you just take a pill and it just kills the cancer cells. So, he's been able to live for many years now a healthy life taking this medication.

[00:00:47]The risk is that those cancer cells morph, and this medicine no longer kills them.

[00:00:53]What Isomorphic Labs is going to do is basically that at scale. So, using AI first, it's going to be able to create very targeted medications that can map exactly the cancer or other disease cells and how to attack them specifically without hurting other healthy cells. Let me give you a a day-in-the-life scenario. So, let's say my dad's cancer cells morph and this miracle drug he's currently taking no longer works.

[00:01:26]Isomorphic Labs, maybe 10, 20 years from now, depending on how long regulatory approvals take, will be able to within a week map the genome of the new cancer cell and create a new tailored medication he can take that just kills those cells. So, it evolves with the harmful cells, and they can make that kind of targeted medicine for in the future, potentially, all diseases.

[00:01:56]Now, obviously, you have red tape, you have human clinical trials that must take time.

[00:02:03]Maybe, you know, the next generation will have it a lot easier in terms of disease.